Table 9 Effect of NAR and NAR-HNPs on hippocampal monoamines and metabolites in experimental rats.

From: Anti-depressant effect of Naringenin-loaded hybridized nanoparticles in diabetic rats via PPARγ/NLRP3 pathway

Groups

Parameters

Hippocampus (μg/g)

NE

5-HT

5-HTAA

DA

DOPAC

Normal

0.62b ± 0.02

0.62b ± 0.05

0.13b ± 0.01

1.50b ± 0.05

0.26b ± 0.02

Free NAR

0.60b ± 0.01

0.62b ± 0.06

0.15b ± 0.01

1.35b ± 0.02

0.25b ± 0.00

NAR-HNPs

0.57b ± 0.02

0.71b ± 0.07

0.14b ± 0.00

1.53b ± 0.07

0.26b ± 0.02

Control STZ

0.43acd ± 0.02

0.36 acd ± 0.01

0.20 acd ± 0.00

1.00 acd ± 0.07

0.35 acd ± 0.01

STZ + unloaded HNPs

0.40 acd ± 0.02

0.40 acd ± 0.03

0.19 acd ± 0.01

1.09 acd ± 0.01

0.34 acd ± 0.00

STZ + NAR (50 mg/kg)

0.53abd ± 0.00

0.54 bd ± 0.01

0.17 abd ± 0.01

1.32 abd ± 0.05

0.27bd ± 0.02

STZ + NAR-HNPs (50 mg/kg)

0.62bc ± 0.01

0.70 bc ± 0.02

0.14bc ± 0.01

1.70abc ± 0.10

0.23 bc ± 0.01

STZ + NAR (50 mg/kg) + GW9662

0.43 acd ± 0.01

0.39 acd ± 0.01

0.20 acd ± 0.01

1.04 acd ± 0.08

0.34 acd ± 0.01

  1. Results are stated as means ± SEM (n = 6), a vs normal group, b vs control STZ group, c vs STZ + NAR (50 mg/kg), d vs STZ + NAR-HNPs (50 mg/kg) at p < 0.05. NAR, naringenin; STZ, streptozotocin; NAR-HNPs, naringenin- loaded hybridized nanoparticles.